You've reached the limit for free Overall Ranking scores. For more information, request a demo.
See CSRHub in Action
You have a total of 10 free searches available.
| Low 0-29 | 30-39 | 40-49 | 50-59 | 60-79 | 80-100 High |
IDL Biotech AB develops, manufactures, and markets products targeted at various forms of cancer and diseases such as Tubex typhoid. The Company provides tests for diagnosis, prognosis, treatment, and monitoring of the patient. IDL works in cooperation with university hospitals. The Company sells and markets internationally.
| Ticker: | IDL |
| ISIN: | SE0012193340 |
| Address: |
NA |
| , , NA, Sweden | |
| Website: | IDL BIOTEC AB |
| Phone #: | NA |
| ESG Web Area: | Subscribers Only ? |
| Industry: | Biotechnology |
We considered many names for our site—in fact we spent our first year and a half under a different name—EkoHub. We liked “Eko” — coming from the Greek word Oikos, related to economy, ecology, and “home” or social concerns. From the beginning, we believed the word “Hub” reflected our desire to be at the center of the sustainability area, providing knowledge, harmony, and consensus among the hundreds of experts judging the ESG performance of companies.